Condition: Drug Resistant Epilepsy · Epilepsy · Epilepsy, Temporal Lobe · Sponsor: NaviFUS Corporation
This will be a prospective, pilot, open-label, two-arm, parallel-group, randomized study to evaluate the efficacy and safety of low-intensity focused ultrasound (LIFU) neuromodulation using NaviFUS System in patients with drug-resistant epilepsy (DRE).
This description comes directly from the study's public registry record.
Sheang-Tze Fung, Ph.D. · 02-25860560 · stfung@navifus.com
Arthur Lung, Ph.D. · arthur.lung@navifus.com
Always discuss trial participation with your own doctor first.
| Taipei Veterans General Hospital | Taipei, Taiwan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06492720